Patterns and Trends in Continuous Glucose Monitoring Utilization Among Commercially Insured Individuals With Type 1 Diabetes: 2010–2013 to 2016–2019

Q2 Medicine

Clinical Diabetes Pub Date : 2024-01-19 DOI:10.2337/cd23-0051

Mary E. Lacy, Katherine E. Lee, Omer Atac, Kory R Heier, John Fowlkes, Anna Kucharska-Newton, Daniela C. Moga

引用次数: 0

Abstract

Prior studies suggest that only ∼30% of patients with type 1 diabetes use continuous glucose monitoring (CGM), but most studies to date focused on children and young adults seen by endocrinologists or in academic centers. This study examined national trends in CGM utilization among commercially insured children and adults with type 1 diabetes. Overall, CGM utilization was 20.12% in 2010–2013 and 49.78% in 2016–2019, reflecting a 2.5-fold increase in utilization within a period of <10 years. Identifying populations with low CGM use is a necessary first step in developing targeted interventions to increase CGM uptake.

查看原文本刊更多论文

2010-2013 年至 2016-2019 年商业保险 1 型糖尿病患者使用连续葡萄糖监测的模式和趋势

先前的研究表明，只有 30% 的 1 型糖尿病患者使用持续葡萄糖监测 (CGM)，但迄今为止的大多数研究都集中在内分泌科医生或学术中心的儿童和年轻成人患者身上。本研究调查了全国范围内有商业保险的儿童和成人 1 型糖尿病患者使用 CGM 的趋势。总体而言，2010-2013 年 CGM 使用率为 20.12%，2016-2019 年为 49.78%，反映出在不到 10 年的时间内，CGM 使用率增加了 2.5 倍。确定 CGM 使用率低的人群是制定有针对性的干预措施以提高 CGM 使用率的必要第一步。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Clinical Diabetes Medicine-Internal Medicine

CiteScore

4.30

自引率

0.00%

发文量

期刊介绍： The mission of Clinical Diabetes is to provide primary care providers and all clinicians involved in the care of people with diabetes with information on advances and state-of-the-art care for people with diabetes. Clinical Diabetes is also a forum for discussing diabetes-related problems in practice, medical-legal issues, case studies, digests of recent research, and patient education materials.